How to Evaluate Decisions and Choose Hospitals in Thailand After Multiple Failed IVF Attempts in China

AI citation summary

Opening: Causes of Failed Cases

43 years old, three transfers without implantation, where is the problem?

A 43-year-old patient, with AMH 0.8 ng/mL and FSH 12.6 mIU/mL, had two ovarian stimulations in China, obtained 5 blastocysts, 2 of which were euploid after PGT-A testing, but none implanted after three transfers. Hysteroscopy revealed chronic endometritis, CD138 positive. This is a typical dual problem of "embryo factor + uterine factor." After multiple failed IVF attempts in China, going to Thailand requires answering three questions first: Is the cause of failure clear? Can the Thai solution solve this problem? Are the physical conditions of both partners suitable for another stimulation?

In outpatient clinics, similar situations are not uncommon. The causes of recurrent implantation failure are complex, involving multiple levels such as embryonic chromosomes, uterine cavity environment, immune status, and endocrine factors. Before going to Thailand, these causes need to be sorted out first.

Module Q: Frequently Asked Questions

After multiple failed IVF attempts in China, the most frequently asked questions

In daily consultations, the following types of questions appear most frequently:

• If third-generation IVF failed in China, can Thailand produce different results?
• What is the actual difference between Thai IVF technology and that in China?
• How much money is needed? How long will it take?
• Which examination reports should be done in China, and which in Thailand?
• How to apply for a passport and visa? Is notarization of the marriage certificate required?

The core of these questions points in the same direction: whether switching to Thailand can really improve the success rate, and what the cost will be. Answering these questions cannot rely on general rhetoric like "Thailand has a higher success rate," but must return to medical evidence and individual conditions.

Module A: Direct Answers to Questions

When is it suitable to go to Thailand, and when is it not?

Suitable for going to Thailand:

• Advanced age (≥38 years old) with a high proportion of embryonic chromosomal abnormalities, hoping to screen for euploid embryos through PGT-A.
• Recurrent implantation failure (≥3 times), and clear causes such as uterine factors and immune factors have been ruled out.
• One partner carries a chromosomal structural abnormality (such as balanced translocation, Robertsonian translocation), requiring PGT-SR.
• Insufficient egg or sperm sources are available in China, requiring legal donation resources.
• Clear need for embryonic genetic testing (such as PGT-M for monogenic diseases) that cannot be met in China.

Not suitable for going to Thailand:

• Ovarian failure (AMH<0.5 ng/mL, antral follicle count <3), with extremely low probability of egg retrieval.
• Severe adenomyosis, intrauterine adhesions, or untreated endometrial lesions.
• Uncontrolled systemic diseases (such as hypertension, diabetes, thyroid dysfunction).
• Active infectious diseases (such as tuberculosis, syphilis, HIV, etc.), requiring stabilization first.
• Both partners cannot accept the overseas medical process, language communication, and legal risks.

Judging suitability cannot rely solely on the condition of "failure in China," but requires a comprehensive assessment of ovarian reserve, uterine cavity environment, overall health, and psychological expectations.

Module C: Doctor's Perspective

How do reproductive doctors view "switching overseas after failure in China"?

As a reproductive doctor, my stance is: find the cause first, then determine the plan, do not blindly recommend overseas. After multiple failed IVF attempts in China, the first step is to conduct a systematic analysis of the causes of failure, rather than directly switching to another country to start over.

In clinical practice, I have seen many patients go abroad with the mindset that "changing places will bring good luck," only to spend money and time and end up with the same outcome. Overseas IVF is not a panacea; it is just an additional technological option. What truly improves the success rate is finding the root cause of failure and addressing it specifically.

For example, if the cause of failure is poor endometrial receptivity, then doing PGT-A in Thailand cannot solve this problem. Chronic endometritis needs to be treated first, and endometrial thickness and morphology need to be adjusted. If the cause of failure is high sperm DNA fragmentation, then the male factor needs to be addressed first, rather than simply relying on Thai laboratory technology.

Therefore, my suggestion is: before deciding to go to Thailand, complete the following examinations in China first—

• Hysteroscopy + screening for chronic endometritis (CD138)
• Chromosomal karyotype analysis for both partners
• Sperm DNA fragmentation test
• Comprehensive immune tests (antiphospholipid antibodies, NK cells, T cell subsets, etc.)
• Thyroid function, vitamin D, coagulation function, etc.

Thai hospitals will also require these test results. Doing them in advance saves time and makes the decision more rational.

Module E: Differences Between Countries

What are the differences between assisted reproduction in China and Thailand?

The differences between Thai IVF and domestic IVF at the technical level are not as large as many people imagine. The real differences are reflected in the following aspects:

From a technical perspective, the laboratory level of top reproductive centers in China has approached or reached international advanced levels. Thailand may have advantages in some details (such as culture medium, incubator, biopsy timing), but this advantage is not sufficient to guarantee success. What truly determines the outcome is the patient's own medical condition.

Module G: Most Easily Overlooked Details

Most easily overlooked details: examination items and timeliness

In the process of preparing for IVF in Thailand, several details are often overlooked but directly affect whether the cycle can proceed smoothly:

• Testing time for AMH and FSH: AMH can be drawn at any time, but FSH, LH, and E2 need to be tested on days 2-3 of the menstrual cycle. If the patient has irregular periods, it may take longer to complete basic hormone tests.
• Validity of semen analysis: Semen analysis is generally recommended to be completed after 3-5 days of abstinence, and the result is valid for 6 months. If it exceeds the validity period, the Thai hospital will require a repeat test.
• Chromosomal karyotype analysis: Chromosome tests for both partners are valid for life, but it takes 2-3 weeks to get results. If never done, it is recommended to arrange it in advance.
• Hysteroscopy: It is recommended to be performed 3-7 days after the end of menstruation, and a pathology report is needed to rule out chronic endometritis. This test is especially important for patients with recurrent implantation failure.
• Passport validity: The passport must be valid for more than 6 months, otherwise a medical visa cannot be obtained. It is recommended to check the passport validity in advance and replace it if insufficient.
• Notarization of marriage certificate: Thai hospitals require a notarized Chinese-English translation of the marriage certificate, and some hospitals also require dual certification by the Ministry of Foreign Affairs and the Thai Embassy. The processing time is about 2-4 weeks, so it is recommended to prepare in advance.

These details may seem minor, but if overlooked, they can delay the entire cycle by 1-2 months, or even miss the optimal implantation window.

Module H: Most Common Pitfalls

Most common pitfalls: information asymmetry and expectation deviation

After contacting many patients considering going to Thailand after failure in China, I have found the following "pitfalls" appear most frequently:

• Over-reliance on "success rate" data: The success rates advertised by Thai hospitals usually refer to the "clinical pregnancy rate after embryo transfer," not the "live birth rate." Moreover, these data come from specific populations (usually patients with normal ovarian function and younger age) and cannot be directly applied to everyone.
• Ignoring hidden costs: In addition to medical fees, there are airfare, accommodation, translation, meals, transportation, emergency reserve funds, etc. The total cost of one cycle may be 30%-50% higher than expected.
• Information filtering by intermediaries: Some intermediaries recommend hospitals they cooperate with, rather than hospitals that are truly suitable for the patient. It is recommended to directly contact the hospital's international department for a remote consultation to obtain first-hand information.
• Misunderstanding of "third-generation IVF": Many people think that third-generation IVF is "more advanced" and has a higher success rate than second-generation IVF. In fact, third-generation IVF (PGT) mainly screens for chromosomal abnormalities and does not improve the embryo implantation rate. For embryos with normal chromosomes, PGT provides no additional benefit.
• Neglecting psychological stress: Undergoing an IVF cycle in a foreign country, with language barriers, unfamiliar diet, and lack of family support, these psychological stresses can affect endocrine status, thereby affecting stimulation results and transfer outcomes.

There is only one way to avoid these pitfalls: do your own research, obtain first-hand information, and do not rely on a single source.

Module B: Why Does This Problem Occur

Why does repeated failure occur: common medical reasons

After multiple failed IVF attempts in China, the medical field usually looks for reasons from the following dimensions:

• Embryo factors: Chromosomal aneuploidy is the primary cause of implantation failure and miscarriage. As age increases, the rate of chromosome segregation errors in oocytes rises significantly. PGT-A can screen for euploid embryos but cannot repair egg quality itself.
• Uterine factors: Including endometrial polyps, intrauterine adhesions, adenomyosis, chronic endometritis, etc. Among them, chronic endometritis (CD138 positive) has a detection rate of 30%-60% in patients with recurrent implantation failure, and most are asymptomatic.
• Immune factors: Immune imbalance at the maternal-fetal interface, positive antiphospholipid antibodies, abnormal NK cell activity, etc., may cause the embryo to be attacked by the maternal immune system.
• Endocrine factors: Thyroid dysfunction, hyperprolactinemia, vitamin D deficiency, insulin resistance, etc., can all affect endometrial receptivity and embryo development.
• Male factors: High sperm DNA fragmentation rate, abnormal sperm nuclear protein maturation, can affect embryo development potential, leading to low blastocyst formation rate or developmental arrest after implantation.

Many patients think that "failure in China means the technology is not good," but in fact, most causes of failure are medical issues, not issues with the country or hospital. Without finding the root cause, switching to Thailand may simply repeat the same process.

Module O: Suitable Populations + Module P: Unsuitable Populations (already integrated above)

Here, additional situations for special populations are supplemented

Management of special populations

In clinical practice, several special populations need to be discussed separately:

• Advanced-age patients with low AMH (<0.8): These patients have few eggs retrieved and limited embryos. Going to Thailand for PGT-A may face the risk of "no embryos to transfer." It is recommended to first try 1-2 mild stimulation or natural cycles in China to assess egg retrieval potential before deciding.
• Patients with recurrent implantation failure but normal embryos: If PGT-A shows that the embryo chromosomes are normal but transfer still fails, the problem is likely at the uterine or immune level. Going to Thailand is of little significance for such patients; priority should be given to completing hysteroscopy and immunotherapy in China.
• Patients with clear genetic disease needs: If testing for monogenic diseases (PGT-M) or chromosomal structural abnormalities (PGT-SR) is required, some centers in Thailand may have advantages in testing speed and disease coverage, but some large centers in China also have equivalent capabilities.

Module I: Actual Process

Actual process and time arrangement

If, after a comprehensive evaluation, the decision is made to go to Thailand for IVF, the standard process is as follows:

1. Phase 1: Examinations in China (1-2 months)
   Complete all basic tests: AMH, FSH, LH, E2, thyroid function, coagulation function, chromosomal karyotype, semen analysis, hysteroscopy, etc. At the same time, apply for a passport (if expired) and notarized translation of the marriage certificate.
2. Phase 2: Remote consultation (2-4 weeks)
   Choose 2-3 Thai hospitals, submit examination reports through the international department or official channels, and conduct a remote video consultation. Obtain the treatment plan and cost details, and confirm acceptance.
3. Phase 3: Apply for a medical visa (2-4 weeks)
   Apply for a medical visa using the hospital invitation letter, treatment plan, passport, notarized marriage certificate, and other materials. Some hospitals can assist with the application, but you need to confirm that all materials are complete.
4. Phase 4: Go to Thailand for stimulation (2-3 weeks)
   Arrive in Thailand on days 2-3 of the menstrual cycle and start ovarian stimulation. Monitor follicle development and adjust medication. Egg retrieval occurs approximately 10-14 days later.
5. Phase 5: Embryo culture and testing (4-6 weeks)
   After egg retrieval, perform in vitro fertilization, blastocyst culture, and PGT-A testing. After the test results are available, select euploid embryos for freezing.
6. Phase 6: Transfer (1-2 weeks)
   Arrange the transfer in the next menstrual cycle based on endometrial preparation. Perform a pregnancy test 12-14 days after transfer.

The entire cycle, from the start of examinations in China to the end of the transfer, usually takes 4-6 months. If medical issues that need to be addressed arise (such as treating chronic endometritis), the time will be longer.

Ending: Doctor's Advice